Pfizer Inc. (NYSE: PFE) kicked off on Monday, down -0.52% from the previous trading day, before settling in for the closing price of $29.09. Over the past 52 weeks, PFE has traded in a range of $25.20-$34.11.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 10.96% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 43.37%. With a float of $5.66 billion, this company’s outstanding shares have now reached $5.67 billion.
In an organization with 88000 employees, it is important to assess its efficiency.
Pfizer Inc. (PFE) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – General Industry. The insider ownership of Pfizer Inc. is 0.03%, while institutional ownership is 67.38%. The most recent insider transaction that took place on Aug 13 ’24, was worth 147,714. In this transaction SVP & Controller of this company sold 5,154 shares at a rate of $28.66, taking the stock ownership to the 8,582 shares. Before that another transaction happened on Dec 15 ’23, when Company’s Director bought 3,000 for $26.47, making the entire transaction worth $79,401. This insider now owns 9,000 shares in total.
Pfizer Inc. (PFE) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 43.37% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.60% during the next five years compared to -27.43% drop over the previous five years of trading.
Pfizer Inc. (NYSE: PFE) Trading Performance Indicators
Take a look at Pfizer Inc.’s (PFE) current performance indicators. Last quarter, stock had a quick ratio of 0.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.95. Likewise, its price to free cash flow for the trailing twelve months is 34.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.46, a number that is poised to hit 0.59 in the next quarter and is forecasted to reach 2.86 in one year’s time.
Technical Analysis of Pfizer Inc. (PFE)
Let’s dig in a bit further. During the last 5-days, its volume was 27.39 million. That was inferior than the volume of 37.59 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 33.82%. Additionally, its Average True Range was 0.56.
During the past 100 days, Pfizer Inc.’s (PFE) raw stochastic average was set at 44.33%, which indicates a significant increase from 30.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 17.00% in the past 14 days, which was lower than the 21.14% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $29.31, while its 200-day Moving Average is $28.14. However, in the short run, Pfizer Inc.’s stock first resistance to watch stands at $29.16. Second resistance stands at $29.38. The third major resistance level sits at $29.57. If the price goes on to break the first support level at $28.75, it is likely to go to the next support level at $28.56. The third support level lies at $28.34 if the price breaches the second support level.
Pfizer Inc. (NYSE: PFE) Key Stats
The company with the Market Capitalisation of 163.99 billion has total of 5,666,593K Shares Outstanding. Its annual sales at the moment are 58,496 M in contrast with the sum of 2,119 M annual income. Company’s last quarter sales were recorded 13,283 M and last quarter income was 41,000 K.
